Single answer
Is Alector Inc (ALEC) a buy or sell?
4starter turns market data into one clear verdict you can act on.
Create a free account to save tickers and track your signals.
Log in to turn on watchlist alerts.
What is the conclusion?
Right now our advanced algorithms say:
Do analysts agree?
We compare consensus targets with today's price.
Consensus target for Alector Inc is $3.25, which is $1.730 (113.82%) above the current price today's price.
Low target: $1.500 | High target: $5.00
Company snapshot
A quick overview of the business and its public profile.
Alector Inc a clinical stage biopharmaceutical company develops therapies for the treatment of neurodegeneration diseases Its products include AL001 a humanized recombinant monoclonal antibody which is in Phase III clinical trial for the treatment of frontotemporal dementia Alzheimers Parkinsons and amyotrophic lateral sclerosis diseases and AL101 that is in Phase I clinical trial for the treatment of neurodegenerative diseases including Alzheimers and Parkinsons diseases The company also offers AL002 a product candidate that is in Phase II clinical trial for the treatment of Alzheimers disease and AL003 which is in Phase I clinical trial for the treatment of Alzheimers disease In addition its products in development stage include AL044 that targets MS4A4A a risk gene for Alzheimers disease Alector Inc has a collaboration agreement with Adimab LLC for the research and development of antibodies and a strategic collaboration agreement with GlaxoSmithKline plc for the development and commercialization of monoclonal antibodies such as AL001 and AL101 to treat neurodegenerative diseases The company was founded in 2013 and is headquartered in South San Francisco California
Website: https://www.alector.com
Rates and inflation backdrop
US inflation for September 2025 was 0.31%. Over the last 12 months, inflation is 3.02%. The 10-year yield is 4.12 and is down -0.1000 over the last 30 days.
Inflation sensitivity
Debt ratio: 0.11. Cash flow to debt ratio: -5.21. Net profit margin: -156.03%. Inflation risk score: high (0.85/1).
Dividend history check
We cannot find any recorded dividends paid in our systems.
Trading liquidity
Yes, the average daily trading liquidity for Alector Inc is $4.3M. You should therefore be able to get in and out of your positions relatively fast.
10-year return check
We cannot find data for Alector Inc 10 years ago, but if you had invested on 2019-02-07 when the price was $18.00, you would have made a loss of $16.48 per share or 91.56%.
Why this answer
We combine price momentum, volatility, and trend signals to simplify the decision to one word.
Signal engine scans price, trend, and momentum indicators.
Targets and sentiment are checked against the live quote.
We keep the output simple: buy, sell, or hold.
Analyst consensus
How Wall Street targets compare to today's price.